P346 Single-centre experience of ustekinumab: Therapeutic drug monitoring in Crohn’s disease patients

Volume: 14, Issue: Supplement_1, Pages: S331 - S333
Published: Jan 1, 2020
Abstract
Background Therapeutic drug monitoring (TDM) is a diagnostic tool in the monitoring of anti-TNF therapies. Yet, the benefit for TDM of new biologics such as ustekinumab (USK) is still controversial in real-world experiences. Methods This monocentric retrospective study aims to correlate USK trough levels (TLs) with clinical and endoscopic data. All patients have given written consent to the Biobank (B2011/005). Endoscopic disease was defined as...
Paper Details
Title
P346 Single-centre experience of ustekinumab: Therapeutic drug monitoring in Crohn’s disease patients
Published Date
Jan 1, 2020
Volume
14
Issue
Supplement_1
Pages
S331 - S333
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.